Lulizol Lotion contains luliconazole 1% w/v, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin caused by dermatophytes, yeasts, and molds. Luliconazole exhibits potent fungicidal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and cell death. This lotion is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis. The formulation allows for effective penetration into the stratum corneum, ensuring targeted antifungal action with minimal systemic absorption. Lulizol Lotion is applied once daily to the affected area and surrounding skin, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. Common adverse effects are generally mild and may include localized burning, itching, or irritation at the application site. It is contraindicated in patients with known hypersensitivity to luliconazole or any components of the formulation. Caution is advised when applying near mucous membranes or broken skin. Use during pregnancy and lactation should be considered only if the potential benefit justifies the potential risk. Lulizol Lotion offers an effective and well-tolerated option for the management of superficial dermatophytic infections.